Kala Pharmaceuticals Revenue, Growth & Competitor Profile

DBA KALA

Company Profile & Annual Report for Kala Pharmaceuticals

Access the complete profile.

Kala Pharmaceuticals Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5411 Legal Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 5417 Scientific Research & Development Services
Address	1167 Massachusetts Avenue Arlington, MA 02476

Note: Revenues for privately held companies are statistical evaluations.


Kala Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Kala Pharmaceuticals's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Kala Pharmaceuticals is classified as operating in the Legal Services industry, NAICS Code 5411.

Kala Pharmaceuticals Annual Revenue and Growth Rate

Kala Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Kala Pharmaceuticals's revenues are gauged from an analysis of company filings.

Kala Pharmaceuticals's Income Statement (based on Industry Averages)

Kala Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Kala Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
November 29, 2021	26	44%	$37 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Kala Pharmaceuticals is developing and marketing. Kala Pharmaceuticals doesn't have any recent trademark applications, indicating Kala Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
EYSUVIS pharmaceutical preparations and substances for the treatment of ophthalmological and ocular diseases and disorders; topical ophthalmic pharmaceutical preparations; topical ophthalmic pharmaceutical preparations for the relief of the signs and symptoms of dry eye disease	08/20/2020
SPEDLYF Pharmaceutical preparations and substances for the treatment of ophthalmological and ocular diseases and disorders; topical ophthalmic pharmaceutical preparations and substances; topical ophthalmic pharmaceutical preparations and substances for the treatment of dryness of the eye or dry eye flares; topical ophthalmic pharmaceutical preparations and substances for temporal relief of the signs and symptoms of dry eye disease or dry eye flares	02/13/2020
RELFLAYRA Pharmaceutical preparations and substances for the treatment of ophthalmological and ocular diseases and disorders; topical ophthalmic pharmaceutical preparations and substances; topical ophthalmic pharmaceutical preparations and substances for the treatment of dryness of the eye or dry eye flares; topical ophthalmic pharmaceutical preparations and substances for temporal relief of the signs and symptoms of dry eye disease or dry eye flares	02/13/2020

See all trademarks and details in the Full Report.

Market Share of Kala Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Kala Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AUSTIN 316 FIDUCIARY LIMITED	Oceanside, NY	100
CONSILIO	Washington, DC	66
LATHAM & WATKINS	Los Angeles, CA	54
KIRKLAND & ELLIS	Chicago, IL	49
CO STATE FRATERNAL ORDER OF POLICE	Westminster, CO	44
GREENBERG TRAURIG P.A.	Miami, FL	42
PROFESSIONAL LAW ENFORCEMENT A	Rochester, MI	38
CHG COMPANIES	Midvale, UT	35
BAKER & MCKENZIE	Chicago, IL	33

Nearby Competitors

These companies are similar in business line and location to Kala Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
MORSE BARNES-BROWN & PENDLETON P.C.	Waltham, MA	100
FABER DAEUFER & ITRATO PC	Waltham, MA	80
LIGRIS & ASSOCIATES PC	Newton, MA	72
CUSHING & DOLAN P.C.	Waltham, MA	60
KAJKO WEISMAN & COLASANTI	Lexington, MA	59
HARMON LAW OFFICES P.C.	Newton, MA	59

Other Companies at 1167 Massachusetts Avenue, Arlington MA

Company	Headquarters	Revenue ($ MM)
GLANCE NETWORKS	Arlington, MA	100
DNB ADVISORY	Arlington, MA	3

Future Competition: Kala Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Kala Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)